Anna M.D. Watson

3.1k total citations
48 papers, 2.5k citations indexed

About

Anna M.D. Watson is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Clinical Biochemistry. According to data from OpenAlex, Anna M.D. Watson has authored 48 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 13 papers in Surgery and 10 papers in Clinical Biochemistry. Recurrent topics in Anna M.D. Watson's work include Advanced Glycation End Products research (10 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (8 papers) and Heart Rate Variability and Autonomic Control (8 papers). Anna M.D. Watson is often cited by papers focused on Advanced Glycation End Products research (10 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (8 papers) and Heart Rate Variability and Autonomic Control (8 papers). Anna M.D. Watson collaborates with scholars based in Australia, Germany and United States. Anna M.D. Watson's co-authors include Karin Jandeleit‐Dahm, Mark E. Cooper, Clive N. May, Merlin C. Thomas, Aino Soro‐Paavonen, Philip Koh, Melinda T. Coughlan, Wendy C. Burns, Phillip Kantharidis and Michael J. McKinley and has published in prestigious journals such as Journal of Neuroscience, Biomaterials and Diabetes.

In The Last Decade

Anna M.D. Watson

46 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna M.D. Watson Australia	26	719	558	463	459	419	48	2.5k
Lisa Hahner United States	21	1.1k 1.5×	326 0.6×	77 0.2×	359 0.8×	641 1.5×	24	3.0k
Camille Attané France	22	676 0.9×	405 0.7×	121 0.3×	112 0.2×	269 0.6×	34	2.2k
Ruby L.C. Hoo Hong Kong	28	1.4k 1.9×	617 1.1×	99 0.2×	290 0.6×	395 0.9×	50	3.5k
Hye Lim Noh United States	26	1.2k 1.7×	456 0.8×	77 0.2×	176 0.4×	445 1.1×	40	2.8k
František Kolář Czechia	31	1.4k 2.0×	1.1k 1.9×	65 0.1×	257 0.6×	317 0.8×	183	3.3k
Fumio Niimura Japan	25	1.5k 2.0×	1.5k 2.7×	207 0.4×	95 0.2×	1.2k 2.9×	57	3.7k
Hema Viswambharan United Kingdom	16	592 0.8×	395 0.7×	40 0.1×	199 0.4×	264 0.6×	39	1.6k
Jean Bastin France	30	1.9k 2.6×	515 0.9×	719 1.6×	48 0.1×	221 0.5×	70	2.9k
Josep Oriola Spain	20	854 1.2×	186 0.3×	138 0.3×	68 0.1×	470 1.1×	77	1.8k
Takeshige Kunieda Japan	11	958 1.3×	343 0.6×	39 0.1×	490 1.1×	106 0.3×	23	2.5k

Countries citing papers authored by Anna M.D. Watson

Since Specialization

Citations

This map shows the geographic impact of Anna M.D. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna M.D. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna M.D. Watson more than expected).

Fields of papers citing papers by Anna M.D. Watson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna M.D. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna M.D. Watson. The network helps show where Anna M.D. Watson may publish in the future.

Co-authorship network of co-authors of Anna M.D. Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Anna M.D. Watson. A scholar is included among the top collaborators of Anna M.D. Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna M.D. Watson. Anna M.D. Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lai, Austin, Azadeh Mirabedini, Jonathan Noonan, et al.. (2025). Decoding vascular aging: Substrate stiffness and shear stress orchestrate endothelial inflammation and remodelling via mechanosensitive pathways. Biomaterials. 329. 123932–123932.

Jackson, Kristy L., Malathi S.I. Dona, Bruna Visniauskas, et al.. (2021). Deficiency of MicroRNA-181a Results in Transcriptome-Wide Cell-Specific Changes in the Kidney and Increases Blood Pressure. Hypertension. 78(5). 1322–1334. 8 indexed citations

Sata, Yusuke, Sandra L. Burke, Nina Eikelis, et al.. (2021). Renal Deafferentation Prevents Progression of Hypertension and Changes to Sympathetic Reflexes in a Rabbit Model of Chronic Kidney Disease. Hypertension. 78(5). 1310–1321. 4 indexed citations

Sata, Yusuke, Sandra L. Burke, Kyungjoon Lim, et al.. (2020). Contribution of the Renal Nerves to Hypertension in a Rabbit Model of Chronic Kidney Disease. Hypertension. 76(5). 1470–1479. 9 indexed citations

Burke, Sandra L., Benjamin Barzel, Nina Eikelis, et al.. (2020). Empagliflozin modulates renal sympathetic and heart rate baroreflexes in a rabbit model of diabetes. Diabetologia. 63(7). 1424–1434. 29 indexed citations

Watson, Anna M.D., Sarah C. Moody, Priyadharshini Sivakumaran, et al.. (2020). Disparate Effects of Diabetes and Hyperlipidemia on Experimental Kidney Disease. Frontiers in Physiology. 11. 518–518. 4 indexed citations

Watson, Anna M.D., Sally A. Penfold, Gavin Lambert, et al.. (2019). Diabetes and Hypertension Differentially Affect Renal Catecholamines and Renal Reactive Oxygen Species. Frontiers in Physiology. 10. 309–309. 14 indexed citations

Cooper, Mark E., Assam El‐Osta, Terri J. Allen, et al.. (2018). Metabolic Karma—The Atherogenic Legacy of Diabetes: The 2017 Edwin Bierman Award Lecture. Diabetes. 67(5). 785–790. 19 indexed citations

Watson, Anna M.D., Murat Olukman, Christine Koulis, et al.. (2013). Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes. Diabetologia. 56(5). 1155–1165. 34 indexed citations

10.

Watson, Anna M.D., Stephen P. Gray, Aino Soro‐Paavonen, et al.. (2012). Alagebrium Reduces Glomerular Fibrogenesis and Inflammation Beyond Preventing RAGE Activation in Diabetic Apolipoprotein E Knockout Mice. Diabetes. 61(8). 2105–2113. 57 indexed citations

11.

Jandeleit‐Dahm, Karin & Anna M.D. Watson. (2011). The endothelin system and endothelin receptor antagonists. Current Opinion in Nephrology & Hypertension. 21(1). 66–71. 13 indexed citations

12.

Wang, Bo, Michal Herman‐Edelstein, Philip Koh, et al.. (2010). E-Cadherin Expression Is Regulated by miR-192/215 by a Mechanism That Is Independent of the Profibrotic Effects of Transforming Growth Factor-β. Diabetes. 59(7). 1794–1802. 221 indexed citations

13.

Tu, Yingfeng, Tingting Wu, Terri J. Allen, et al.. (2009). Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-β in a murine diabetic model of atherosclerosis. Diabetologia. 53(1). 170–179. 29 indexed citations

14.

Jandeleit‐Dahm, Karin, Anna M.D. Watson, & Aino Soro‐Paavonen. (2008). THE AGE/RAGE AXIS IN DIABETES‐ACCELERATED ATHEROSCLEROSIS. Clinical and Experimental Pharmacology and Physiology. 35(3). 329–334. 62 indexed citations

15.

Watson, Anna M.D., Sally G. Hood, Rohit Ramchandra, Robin M. McAllen, & Clive N. May. (2007). Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex. American Journal of Physiology-Heart and Circulatory Physiology. 293(1). H798–H804. 60 indexed citations

16.

Watson, Anna M.D., et al.. (2006). MECHANISMS OF SYMPATHETIC ACTIVATION IN HEART FAILURE. Clinical and Experimental Pharmacology and Physiology. 33(12). 1269–1274. 82 indexed citations

17.

Hood, Sally G., Anna M.D. Watson, & Clive N. May. (2005). Cardiac actions of central but not peripheral urotensin II are prevented by β-adrenoceptor blockade. Peptides. 26(7). 1248–1256. 22 indexed citations

18.

Watson, Anna M.D., Rasim Moğulkoç, Robin M. McAllen, & Clive N. May. (2004). Stimulation of cardiac sympathetic nerve activity by central angiotensinergic mechanisms in conscious sheep. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 286(6). R1051–R1056. 41 indexed citations

19.

Watson, Anna M.D. & Clive N. May. (2004). Urotensin II, a novel peptide in central and peripheral cardiovascular control. Peptides. 25(10). 1759–1766. 29 indexed citations

20.

Kocharyan, Arminé, Martina Pyrski, Thomas Hübschle, et al.. (2003). Leptin‐Target Neurones of the Rat Hypothalamus Express Somatostatin Receptors. Journal of Neuroendocrinology. 15(9). 822–830. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact